outdoordreams
Active member
Hello everyone.
I have a friend who has Myasthenia Gravis, an extremely rare auto-immune disease similar to MS. She is taking Mestinon at 60mg, 4 times a day. She uses Cannabis so that she can eat and sleep, mostly to counter act the Mestinon side effects.
Does anyone else have any experience with Myasthenia Gravis?
I read one post on another site with a person claiming with Cannabis use they stopped using the Mestinon.
Other posts stated they thought it makes the disease worse.
Thanks for your replies.
Myasthenia gravis (from Greek μύς "muscle", ἀσθένεια "weakness", and Latin: gravis "serious"; abbreviated MG) is an autoimmune neuromuscular disease leading to fluctuating muscle weakness and fatiguability. It is an autoimmune disorder, in which weakness is caused by circulating antibodies that block acetylcholine receptors at the postsynaptic neuromuscular junction,[1] inhibiting the excitatory effects of the neurotransmitter acetylcholine on nicotinic receptors throughout neuromuscular junctions. Myasthenia is treated medically with cholinesterase inhibitors or immunosuppressants, and, in selected cases, thymectomy. The disease incidence is 3–30 cases per million per year and rising as a result of increased awareness.[2] MG must be distinguished from congenital myasthenic syndromes that can present similar symptoms but offer no response to immunosuppressive treatments.
I have a friend who has Myasthenia Gravis, an extremely rare auto-immune disease similar to MS. She is taking Mestinon at 60mg, 4 times a day. She uses Cannabis so that she can eat and sleep, mostly to counter act the Mestinon side effects.
Does anyone else have any experience with Myasthenia Gravis?
I read one post on another site with a person claiming with Cannabis use they stopped using the Mestinon.
Other posts stated they thought it makes the disease worse.
Thanks for your replies.
Myasthenia gravis (from Greek μύς "muscle", ἀσθένεια "weakness", and Latin: gravis "serious"; abbreviated MG) is an autoimmune neuromuscular disease leading to fluctuating muscle weakness and fatiguability. It is an autoimmune disorder, in which weakness is caused by circulating antibodies that block acetylcholine receptors at the postsynaptic neuromuscular junction,[1] inhibiting the excitatory effects of the neurotransmitter acetylcholine on nicotinic receptors throughout neuromuscular junctions. Myasthenia is treated medically with cholinesterase inhibitors or immunosuppressants, and, in selected cases, thymectomy. The disease incidence is 3–30 cases per million per year and rising as a result of increased awareness.[2] MG must be distinguished from congenital myasthenic syndromes that can present similar symptoms but offer no response to immunosuppressive treatments.